Interferons α and β in cancer: therapeutic opportunities from new insights
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferons α and β in cancer: therapeutic opportunities from new insights
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 18, Issue 3, Pages 219-234
Publisher
Springer Nature
Online
2019-01-24
DOI
10.1038/s41573-018-0011-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy
- (2018) David G. Leach et al. BIOMATERIALS
- A novel chemical compound SINCRO with dual function in the STING-type I interferon and tumor cell death pathways
- (2018) Yoshitaka Kimura et al. CANCER SCIENCE
- An overview on Vadimezan (DMXAA): The vascular disrupting agent
- (2018) Amir Daei Farshchi Adli et al. Chemical Biology & Drug Design
- Negative regulation of type I IFN signaling
- (2018) Kei-Ichiro Arimoto et al. JOURNAL OF LEUKOCYTE BIOLOGY
- On taking the STING out of immune activation
- (2018) Andra Banete et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chromosomal instability drives metastasis through a cytosolic DNA response
- (2018) Samuel F. Bakhoum et al. NATURE
- BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis
- (2018) Kate McArthur et al. SCIENCE
- Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association
- (2018) Solana Alculumbre et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- cGAS–STING and Cancer: Dichotomous Roles in Tumor Immunity and Development
- (2018) Kevin W. Ng et al. TRENDS IN IMMUNOLOGY
- ISG15 in cancer: Beyond ubiquitin-like protein
- (2018) Hye Gyeong Han et al. CANCER LETTERS
- Interferon‐induced transmembrane protein 1‐mediated EGFR/SOX2 signaling axis is essential for progression of non‐small cell lung cancer
- (2018) Ying‐Gui Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis
- (2017) Natalie J. Ives et al. EUROPEAN JOURNAL OF CANCER
- Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon α-mediated inhibition of angiogenesis
- (2017) Kuo-Sheng Hsu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
- (2017) Bridget Larkin et al. JOURNAL OF IMMUNOLOGY
- Combining Type I Interferons and 5-Aza-2′-Deoxycitidine to Improve Anti-Tumor Response against Melanoma
- (2017) Valeria Lucarini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- A STING-activating nanovaccine for cancer immunotherapy
- (2017) Min Luo et al. Nature Nanotechnology
- Overexpression of Interferon Regulatory Factor 7 (IRF7) Reduces Bone Metastasis of Prostate Cancer Cells in Mice
- (2017) Yang Zhao et al. ONCOLOGY RESEARCH
- Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
- (2017) Mary R. Doherty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- cGAS is essential for the antitumor effect of immune checkpoint blockade
- (2017) Hua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma
- (2017) Lauryn R. Werner et al. RADIOTHERAPY AND ONCOLOGY
- The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy
- (2017) Yuanbing Wu et al. Translational Research
- Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways
- (2017) Alessandra Zevini et al. TRENDS IN IMMUNOLOGY
- Evolutionary Origins of cGAS-STING Signaling
- (2017) Shally R. Margolis et al. TRENDS IN IMMUNOLOGY
- Responses to Cytokines and Interferons that Depend upon JAKs and STATs
- (2017) George R. Stark et al. Cold Spring Harbor Perspectives in Biology
- IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP
- (2017) K. L. Jønsson et al. Nature Communications
- IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes
- (2017) Jessica F. Almine et al. Nature Communications
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- RIG-I: a multifunctional protein beyond a pattern recognition receptor
- (2017) Xiao-xiao Xu et al. Protein & Cell
- RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation
- (2017) Christina Engel et al. Cancer Immunology Research
- A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
- (2017) Jeremy B. Foote et al. Cancer Immunology Research
- The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
- (2017) Julia M. Weiss et al. OncoImmunology
- Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma
- (2017) Aamir Zainulabadeen et al. PLoS One
- STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation
- (2016) Ken Takashima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Apoptotic properties of the type 1 interferon induced family of human mitochondrial membrane ISG12 proteins
- (2016) Heidi Gytz et al. BIOLOGY OF THE CELL
- MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
- (2016) Young-Ae Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Innate immune signaling and regulation in cancer immunotherapy
- (2016) Leticia Corrales et al. CELL RESEARCH
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma
- (2016) Jin-feng Zhang et al. HUMAN PATHOLOGY
- The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA
- (2016) Elizabeth E. Gray et al. IMMUNITY
- IFN-λ cancer immunotherapy: new kid on the block
- (2016) Ahmed Lasfar et al. Immunotherapy
- ISG15 inhibits cancer cell growth and promotes apoptosis
- (2016) Mei-Juan Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The host STING pathway at the interface of cancer and immunity
- (2016) Leticia Corrales et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- Seamless Oncology-Drug Development
- (2016) Tatiana M. Prowell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma
- (2016) Ruth Heise et al. PLoS One
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- The relationship between total and phosphorylated STAT1 and STAT3 tumour cell expression, components of tumour microenvironment and survival in patients with invasive ductal breast cancer
- (2016) Fadia J.A. Gujam et al. Oncotarget
- Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
- (2016) Diana Rose E. Ranoa et al. Oncotarget
- Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
- (2016) Tianli Xia et al. Cell Reports
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils
- (2016) Ekaterina Pylaeva et al. Frontiers in Immunology
- Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
- (2016) Sarah L. Pogue et al. PLoS One
- Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer
- (2015) Marie-Emmanuelle Legrier et al. BRITISH JOURNAL OF CANCER
- Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
- (2015) Yannick Willemen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IFITM1 promotes the metastasis of human colorectal cancer via CAV-1
- (2015) Fang Yu et al. CANCER LETTERS
- Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
- (2015) J. R. Baird et al. CANCER RESEARCH
- Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression
- (2015) David Anz et al. CANCER RESEARCH
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Viral RNA detection by RIG-I-like receptors
- (2015) Mitsutoshi Yoneyama et al. CURRENT OPINION IN IMMUNOLOGY
- Divergent effects of type-I interferons on regulatory T cells
- (2015) Silvia Piconese et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists
- (2015) Martin Kreutz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung
- (2015) Ching-Fang Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Type IIFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human
- (2015) Lisa Andzinski et al. INTERNATIONAL JOURNAL OF CANCER
- Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
- (2015) GABRIEL G. VEGA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Toxicities of Immunotherapy for the Practitioner
- (2015) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Interferon-Beta, a Decisive Factor in Angiogenesis and Arteriogenesis
- (2015) Cansu Yıldırım et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness
- (2015) Pil Soo Sung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
- (2015) Olivier Demaria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
- (2015) S. Liu et al. SCIENCE
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Dynamic control of type I IFN signalling by an integrated network of negative regulators
- (2015) Rebecca A. Porritt et al. TRENDS IN IMMUNOLOGY
- Interferons and viruses: an evolutionary arms race of molecular interactions
- (2015) Hans-Heinrich Hoffmann et al. TRENDS IN IMMUNOLOGY
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- MicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune Response
- (2015) Samuel C. Forster et al. Frontiers in Immunology
- Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias
- (2015) Christine Schneckenleithner et al. Oncotarget
- Alterations of immune response of non-small cell lung cancer with Azacytidine
- (2015) John Wrangle et al. Oncotarget
- Interferon-Stimulated Genes: A Complex Web of Host Defenses
- (2014) William M. Schneider et al. Annual Review of Immunology
- Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids
- (2014) Jiaxi Wu et al. Annual Review of Immunology
- Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
- (2014) Xuanming Yang et al. CANCER CELL
- Type I IFN gene delivery suppresses regulatory T cells within tumors
- (2014) H Hashimoto et al. CANCER GENE THERAPY
- Interferons: Success in anti-viral immunotherapy
- (2014) Fan-ching Lin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinoma
- (2014) Samantha Cohen et al. GYNECOLOGIC ONCOLOGY
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- (2014) Liufu Deng et al. IMMUNITY
- Host STAT2/type I interferon axis controls tumor growth
- (2014) Chanyu Yue et al. INTERNATIONAL JOURNAL OF CANCER
- Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10
- (2014) SHINGO TAKANO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- IFN- Induces Transcription of Hypoxia-Inducible Factor-1 to Inhibit Proliferation of Human Endothelial Cells
- (2014) S. A. Gerber et al. JOURNAL OF IMMUNOLOGY
- Type I Interferon in the Pathogenesis of Lupus
- (2014) M. K. Crow JOURNAL OF IMMUNOLOGY
- Therapeutic Activity of High-Dose Intratumoral IFN-β Requires Direct Effect on the Tumor Vasculature
- (2014) Robbert M. Spaapen et al. JOURNAL OF IMMUNOLOGY
- STING-Mediated DNA Sensing Promotes Antitumor and Autoimmune Responses to Dying Cells
- (2014) Jared Klarquist et al. JOURNAL OF IMMUNOLOGY
- Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia
- (2014) D Saulep-Easton et al. LEUKEMIA
- Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib
- (2014) L. Legros et al. LEUKEMIA RESEARCH
- Interferon Receptor Signaling in Malignancy: A Network of Cellular Pathways Defining Biological Outcomes
- (2014) E. N. Fish et al. MOLECULAR CANCER RESEARCH
- Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer
- (2014) Maurizio Callari et al. Molecular Oncology
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
- (2014) Peter S. Linsley et al. PLoS One
- RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation
- (2014) R. C. Widau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis
- (2014) Shanora G. Brown et al. PROSTATE
- Interferons and Their Stimulated Genes in the Tumor Microenvironment
- (2014) HyeonJoo Cheon et al. SEMINARS IN ONCOLOGY
- Interferon-Induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1-2 N0 Breast Cancer Treated with Breast-Conserving Surgery and Radiation Therapy (BCS + RT)
- (2013) Hasan H. Danish et al. Breast Journal
- Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma
- (2013) Jin Hou et al. CANCER CELL
- ECOG Phase II Trial of Graded-Dose Peginterferon -2b in Patients with Metastatic Melanoma Overexpressing Basic Fibroblast Growth Factor (E2602)
- (2013) R. S. Go et al. CLINICAL CANCER RESEARCH
- Fine tuning type I interferon responses
- (2013) Paul J. Hertzog et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response
- (2013) Lára Hannesdóttir et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Self-priming determines high type I IFN production by plasmacytoid dendritic cells
- (2013) Sarah Kim et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Modulation of antitumour immune responses by intratumoural Stat1 expression
- (2013) Nicole L Messina et al. IMMUNOLOGY AND CELL BIOLOGY
- Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial
- (2013) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: IL-12 and Type I IFN Differentially Program CD8 T Cells for Programmed Death 1 Re-expression Levels and Tumor Control
- (2013) M. Y. Gerner et al. JOURNAL OF IMMUNOLOGY
- Anti-CD20-Interferon-β Fusion Protein Therapy of Murine B-Cell Lymphomas
- (2013) Kham R. Trinh et al. JOURNAL OF IMMUNOTHERAPY
- A Death-Promoting Role for ISG54/IFIT2
- (2013) Nancy C. Reich JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP
- (2013) Andrea Ablasser et al. NATURE
- Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
- (2013) X.-D. Li et al. SCIENCE
- Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities
- (2012) J. Tel et al. BLOOD
- Guanylate-binding protein 1 expression from embryonal endothelial progenitor cells reduces blood vessel density and cellular apoptosis in an axially vascularised tissue-engineered construct
- (2012) Oliver Bleiziffer et al. BMC BIOTECHNOLOGY
- Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
- (2012) V. Sisirak et al. CANCER RESEARCH
- GBP-1 acts as a tumor suppressor in colorectal cancer cells
- (2012) Nathalie Britzen-Laurent et al. CARCINOGENESIS
- Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth
- (2012) N. N. Khodarev et al. CLINICAL CANCER RESEARCH
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Promyelocytic Leukemia Protein (PML) Regulates Endothelial Cell Network Formation and Migration in Response to Tumor Necrosis Factor α (TNFα) and Interferon α (IFNα)
- (2012) Xiwen Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Type I IFN Drives a Distinctive Dendritic Cell Maturation Phenotype That Allows Continued Class II MHC Synthesis and Antigen Processing
- (2012) D. P. Simmons et al. JOURNAL OF IMMUNOLOGY
- TRAIL+ Human Plasmacytoid Dendritic Cells Kill Tumor Cells In Vitro: Mechanisms of Imiquimod- and IFN- -Mediated Antitumor Reactivity
- (2012) M. L. Kalb et al. JOURNAL OF IMMUNOLOGY
- CD8 T Cell Priming in the Presence of IFN- Renders CTLs with Improved Responsiveness to Homeostatic Cytokines and Recall Antigens: Important Traits for Adoptive T Cell Therapy
- (2012) S. Hervas-Stubbs et al. JOURNAL OF IMMUNOLOGY
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- INTERFEROME v2.0: an updated database of annotated interferon-regulated genes
- (2012) Irina Rusinova et al. NUCLEIC ACIDS RESEARCH
- Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
- (2012) Romina Elizabeth Lenci et al. PLoS One
- p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs
- (2012) K. I. Leonova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
- (2012) J. Wu et al. SCIENCE
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response
- (2012) Patricio Godoy et al. Breast Cancer
- A signature of immune function genes associated with recurrence-free survival in breast cancer patients
- (2011) Maria Libera Ascierto et al. BREAST CANCER RESEARCH AND TREATMENT
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
- (2011) B. C. Burnette et al. CANCER RESEARCH
- Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival
- (2011) Martha L. Slattery et al. CARCINOGENESIS
- CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2011) C. Zoglmeier et al. CLINICAL CANCER RESEARCH
- Beta-interferon for multiple sclerosis
- (2011) Richard A. Rudick et al. EXPERIMENTAL CELL RESEARCH
- Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice
- (2011) Huihui Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Gene Regulatory and Clinical Effects of Interferon β in Patients with Metastatic Melanoma: A Phase II Trial
- (2011) Ernest C. Borden et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma
- (2011) Raphael Butsch et al. LEUKEMIA & LYMPHOMA
- G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer
- (2011) V Cheriyath et al. ONCOGENE
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
- (2010) C. Xuan et al. BLOOD
- Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
- (2010) G. Schiavoni et al. CANCER RESEARCH
- Genetic variation in RNASEL associated with prostate cancer risk and progression
- (2010) Mara S. Meyer et al. CARCINOGENESIS
- Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy
- (2010) Juan Dubrot et al. INTERNATIONAL JOURNAL OF CANCER
- Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model
- (2010) Jadwiga Jablonska et al. JOURNAL OF CLINICAL INVESTIGATION
- IFN- and Self-MHC Divert CD8 T Cells into a Distinct Differentiation Pathway Characterized by Rapid Acquisition of Effector Functions
- (2010) H. D. Marshall et al. JOURNAL OF IMMUNOLOGY
- APC Activation by IFN- Decreases Regulatory T Cell and Enhances Th Cell Functions
- (2010) L. Pace et al. JOURNAL OF IMMUNOLOGY
- Emerging Roles of FAM14 Family Members (G1P3/ISG 6–16 and ISG12/IFI27) in Innate Immunity and Cancer
- (2010) Venugopalan Cheriyath et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The Guanylate-Binding Proteins: Emerging Insights into the Biochemical Properties and Functions of This Family of Large Interferon-Induced Guanosine Triphosphatase
- (2010) Deborah J. Vestal et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Unknown
- (2010) Karoline Lipnik et al. MOLECULAR MEDICINE
- STAT1 represses hypoxia-inducible factor-1-mediated transcription
- (2009) Miki Hiroi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CD20-targeted tetrameric interferon- , a novel and potent immunocytokine for the therapy of B-cell lymphomas
- (2009) E. A. Rossi et al. BLOOD
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Inhibition of Tumor Cell Motility by the Interferon-inducible GTPase MxA
- (2009) J. Frederic Mushinski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin α4 expression
- (2008) Kristina Weinländer et al. FASEB JOURNAL
- Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy
- (2008) Elisabeth Naschberger et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of Interferon-β-Stimulated Genes that Inhibit Angiogenesis In Vitro
- (2008) Kevin L. Taylor et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
- (2008) R. R. Weichselbaum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now